AI-driven interpretation of genomic complexity will deliver exciting new categories of capability for therapeutics developers.

From cancer to cardiovascular disease, a fundamentally new way of understanding drugs with polygenic effects is emerging.

It's early, but the self-attention transformer architecture has proven it can generalize very well on RNA sequencing data.

At zeroshot bio, we're creating massive zebrafish datasets to train biology foundation models that deliver next-generation confidence to our therapeutics development customers.

Email steven@zeroshot.bio

if you'd like to get in touch.